BSECompany Update31 Jul 2026 · 31 Jul 2026, 05:49 pm
Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Medplus Health Services Ltd · 543427
✦ AI Summary▼ NegativeRegulatory
Medplus Health Services Ltd's subsidiary, Optival Health Solutions Private Limited, received a five-day suspension order for a drug license of a store in Telangana due to a contravention under the Drugs and Cosmetics Act, 1940.
Analysis Scores
Earnings Impact2/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk6/10
Balance Sheet Risk0/10
Liquidity Impact8/10
Market Sentiment4/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Medplus Health Services Ltd - 543427 - Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Attachments (1)
📄pdf
Download →
5b0fd16b-60be-47cc-bc47-51e49039ea30.pdf
View document text
MedPlus Health Services Limited
July 31, 2026
The Listing Department The Listing Department
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejebhoy Towers, Exchange Plaza, 5th Floor
Dalal Street, Fort, Plot No. C/1, G Block,
Mumbai – 400001 Bandra - Kurla Complex
BSE Scrip Code: 543427 Bandra (East), Mumbai – 400051
NSE Symbol: MEDPLUS
Dear Sir/Madam,
Sub: Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015
We would like to inform you that Optival Health Solutions Private Limited, a subsidiary of the company, has received one
suspension order for a Drug License of a store situated in the state of Telangana:
Pursuant to SEBI Listing Regulations read along with SEBI Master Circular No. HO/49/14/14(7)2025-CFD
POD2/I/3762/2026 dated January 30, 2026, the details of the matter are as follows:
Name(s) of the Nature and details of the Date of receipt of Details of the Impact on
Authority action(s) taken, initiated direction or order, violation(s)/ financial
or order(s) passed including any contravention(s) operation or
interim or interim committed or other activities of
orders, or any alleged to be the listed entity,
other committed quantifiable in
communication monetary terms
from the to the extent
authority possible
Assistant Director, Drugs Suspension of Drug License Order received on Under Rule 65 of Potential Revenue
Control Administration, for five days of store 30.07.2026 Drugs and Cosmetics Loss of Rs 2.34
Warangal, Telangana situated at SBH Colony Act, 1940 and Drugs lacs.
Hanamkonda, Telangana and Cosmetics Rules,
1945
The same will be available on the website of the Company at www.medplusindia.com and also on the websites of BSE
Limited and National Stock Exchange of India Ltd. viz. www.bseindia.com and www.nseindia.com respectively. Kindly take
the same on records.
For MedPlus Health Services Limited
Shrenik Soni
Company Secretary & Compliance Officer
(M. No. F12400)
040-6724 672
Regd. off. H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad – 500037, Telangana, India
CIN No: L85110TG2006PLC051845 I Website: www.medplusindia.com I Email:medplus@medplusindia.com